ID   CATE_RAT                Reviewed;         398 AA.
AC   P16228; Q63701;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   29-MAY-2024, entry version 184.
DE   RecName: Full=Cathepsin E;
DE            EC=3.4.23.34;
DE   Flags: Precursor;
GN   Name=Ctse;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT SER-114.
RC   TISSUE=Spleen;
RX   PubMed=7574663; DOI=10.1006/abbi.1995.1441;
RA   Okamoto K., Yu H., Misumi Y., Ikehara Y., Yamamoto K.;
RT   "Isolation and sequencing of two cDNA clones encoding rat spleen cathepsin
RT   E and analysis of the activation of purified procathepsin E.";
RL   Arch. Biochem. Biophys. 322:103-111(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 59-110, AND GLYCOSYLATION.
RX   PubMed=2105725; DOI=10.1016/0006-291x(90)90914-9;
RA   Yonezawa S., Takahashi T., Ichinose M., Miki K., Tanaka J., Gasa S.;
RT   "Structural studies of rat cathepsin E: amino-terminal structure and
RT   carbohydrate units of mature enzyme.";
RL   Biochem. Biophys. Res. Commun. 166:1032-1038(1990).
RN   [4]
RP   GLYCOSYLATION.
RX   PubMed=8346912; DOI=10.1006/abbi.1993.1361;
RA   Takeda-Ezaki M., Yamamoto K.;
RT   "Isolation and biochemical characterization of procathepsin E from human
RT   erythrocyte membranes.";
RL   Arch. Biochem. Biophys. 304:352-358(1993).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=8339772; DOI=10.1006/exnr.1993.1088;
RA   Nakanishi H., Tsukuba T., Kondou T., Tanaka T., Yamamoto K.;
RT   "Transient forebrain ischemia induces increased expression and specific
RT   localization of cathepsins E and D in rat hippocampus and neostriatum.";
RL   Exp. Neurol. 121:215-223(1993).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8491674; DOI=10.1007/bf00269138;
RA   Finzi G., Cornaggia M., Capella C., Fiocca R., Bosi F., Solcia E.,
RA   Samloff I.M.;
RT   "Cathepsin E in follicle associated epithelium of intestine and tonsils:
RT   localization to M cells and possible role in antigen processing.";
RL   Histochemistry 99:201-211(1993).
RN   [7]
RP   CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8157122; DOI=10.1006/exnr.1994.1048;
RA   Nakanishi H., Tominaga K., Amano T., Hirotsu I., Inoue T., Yamamoto K.;
RT   "Age-related changes in activities and localizations of cathepsins D, E, B,
RT   and L in the rat brain tissues.";
RL   Exp. Neurol. 126:119-128(1994).
RN   [8]
RP   TISSUE SPECIFICITY, AND DEXAMETHASONE ADMINISTRATION.
RX   PubMed=8809073; DOI=10.1006/abbi.1996.0401;
RA   Nishishita K., Sakai H., Sakai E., Kato Y., Yamamoto K.;
RT   "Age-related and dexamethasone-induced changes in cathepsins E and D in rat
RT   thymic and splenic cells.";
RL   Arch. Biochem. Biophys. 333:349-358(1996).
RN   [9]
RP   SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=9572291; DOI=10.1046/j.1471-4159.1998.70052045.x;
RA   Sastradipura D.F., Nakanishi H., Tsukuba T., Nishishita K., Sakai H.,
RA   Kato Y., Gotow T., Uchiyama Y., Yamamoto K.;
RT   "Identification of cellular compartments involved in processing of
RT   cathepsin E in primary cultures of rat microglia.";
RL   J. Neurochem. 70:2045-2056(1998).
CC   -!- FUNCTION: May have a role in immune function. Probably involved in the
CC       processing of antigenic peptides during MHC class II-mediated antigen
CC       presentation. May play a role in activation-induced lymphocyte
CC       depletion in the thymus, and in neuronal degeneration and glial cell
CC       activation in the brain (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Similar to cathepsin D, but slightly broader specificity.;
CC         EC=3.4.23.34; Evidence={ECO:0000269|PubMed:8157122};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000269|PubMed:9572291}.
CC   -!- SUBCELLULAR LOCATION: Endosome {ECO:0000269|PubMed:8491674,
CC       ECO:0000269|PubMed:9572291}. Note=The proenzyme is localized to the
CC       endoplasmic reticulum and Golgi apparatus, while the mature enzyme is
CC       localized to the endosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P16228-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P16228-2; Sequence=VSP_005224;
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in lymphocytes and macrophages
CC       of the thymus and spleen, and in the M cells of the intestine. In the
CC       brain, expression is limited to reactive microglial cells, the large
CC       pyrimidial neurons in the cerebral cortex, the CA1 and CA3 pyrimidial
CC       neurons of the hippocampus, the large neurons of the neostriatum, and
CC       the Purkinje neurons of the cerebellum. {ECO:0000269|PubMed:8157122,
CC       ECO:0000269|PubMed:8339772, ECO:0000269|PubMed:8491674,
CC       ECO:0000269|PubMed:8809073, ECO:0000269|PubMed:9572291}.
CC   -!- DEVELOPMENTAL STAGE: Expression increases in all brain regions examined
CC       with age, and increases markedly in reactive microglial cells amd CA1
CC       pyrimidial neurons following ischemic injury. In the thymus expression
CC       increased steadily up to 8 weeks of age before decreasing to a much
CC       lower level by 52 weeks. Expression levels in the spleen and stomach do
CC       not appear to vary with age. {ECO:0000269|PubMed:8157122}.
CC   -!- PTM: Glycosylated. The nature of the carbohydrate chain varies between
CC       cell types. In brain microglia, the proenzyme contains a high mannose-
CC       type oligosaccharide, while the mature enzyme contains a complex-type
CC       oligosaccharide. In stomach and spleen, the mature enzyme contains a
CC       high mannose-type oligosaccharide. In erythrocyte membranes, the mature
CC       enzyme contains a complex-type oligosaccharide.
CC       {ECO:0000269|PubMed:2105725, ECO:0000269|PubMed:8346912,
CC       ECO:0000269|PubMed:9572291}.
CC   -!- MISCELLANEOUS: Administration of dexamethasone results in the
CC       conversion of the proenzyme to the mature form in thymocytes.
CC   -!- SIMILARITY: Belongs to the peptidase A1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38104; BAA07285.1; -; mRNA.
DR   EMBL; D45187; BAA08128.1; -; mRNA.
DR   EMBL; BC062002; AAH62002.1; -; mRNA.
DR   PIR; A34657; A34657.
DR   PIR; S66465; S66465.
DR   PIR; S66466; S66466.
DR   RefSeq; NP_037070.1; NM_012938.1. [P16228-2]
DR   RefSeq; XP_006249810.1; XM_006249748.2.
DR   RefSeq; XP_006249811.1; XM_006249749.2. [P16228-1]
DR   RefSeq; XP_017454166.1; XM_017598677.1.
DR   AlphaFoldDB; P16228; -.
DR   SMR; P16228; -.
DR   STRING; 10116.ENSRNOP00000048353; -.
DR   MEROPS; A01.010; -.
DR   GlyCosmos; P16228; 1 site, No reported glycans.
DR   GlyGen; P16228; 1 site.
DR   PhosphoSitePlus; P16228; -.
DR   PaxDb; 10116-ENSRNOP00000048353; -.
DR   Ensembl; ENSRNOT00000009241.4; ENSRNOP00000009242.2; ENSRNOG00000006963.7. [P16228-2]
DR   Ensembl; ENSRNOT00000048391.5; ENSRNOP00000048353.2; ENSRNOG00000006963.7. [P16228-1]
DR   Ensembl; ENSRNOT00065032756; ENSRNOP00065026181; ENSRNOG00065019437. [P16228-1]
DR   GeneID; 25424; -.
DR   KEGG; rno:25424; -.
DR   UCSC; RGD:2446; rat. [P16228-1]
DR   AGR; RGD:2446; -.
DR   CTD; 1510; -.
DR   RGD; 2446; Ctse.
DR   eggNOG; KOG1339; Eukaryota.
DR   GeneTree; ENSGT00940000161300; -.
DR   HOGENOM; CLU_013253_3_0_1; -.
DR   InParanoid; P16228; -.
DR   OMA; YGVECAN; -.
DR   OrthoDB; 1120702at2759; -.
DR   PhylomeDB; P16228; -.
DR   TreeFam; TF314990; -.
DR   BRENDA; 3.4.23.34; 5301.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   PRO; PR:P16228; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000006963; Expressed in stomach and 17 other cell types or tissues.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008233; F:peptidase activity; ISO:RGD.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IDA:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; IMP:RGD.
DR   GO; GO:0006508; P:proteolysis; ISO:RGD.
DR   Gene3D; 6.10.140.60; -; 1.
DR   Gene3D; 2.40.70.10; Acid Proteases; 2.
DR   InterPro; IPR001461; Aspartic_peptidase_A1.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR012848; Aspartic_peptidase_N.
DR   InterPro; IPR033121; PEPTIDASE_A1.
DR   InterPro; IPR021109; Peptidase_aspartic_dom_sf.
DR   PANTHER; PTHR47966; BETA-SITE APP-CLEAVING ENZYME, ISOFORM A-RELATED; 1.
DR   PANTHER; PTHR47966:SF26; CATHEPSIN E; 1.
DR   Pfam; PF07966; A1_Propeptide; 1.
DR   Pfam; PF00026; Asp; 1.
DR   PRINTS; PR00792; PEPSIN.
DR   SUPFAM; SSF50630; Acid proteases; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
DR   PROSITE; PS51767; PEPTIDASE_A1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aspartyl protease; Autocatalytic cleavage;
KW   Direct protein sequencing; Disulfide bond; Endosome; Glycoprotein;
KW   Hydrolase; Protease; Reference proteome; Signal; Zymogen.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000250"
FT   PROPEP          22..58
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000269|PubMed:2105725"
FT                   /id="PRO_0000025980"
FT   CHAIN           59..398
FT                   /note="Cathepsin E"
FT                   /id="PRO_0000025981"
FT   DOMAIN          80..394
FT                   /note="Peptidase A1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01103"
FT   ACT_SITE        98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10094"
FT   ACT_SITE        283
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10094"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   DISULFID        62
FT                   /note="Interchain"
FT                   /evidence="ECO:0000305"
FT   DISULFID        111..116
FT                   /evidence="ECO:0000250"
FT   DISULFID        274..278
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         312..344
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7574663"
FT                   /id="VSP_005224"
FT   VARIANT         114
FT                   /note="P -> S"
FT                   /evidence="ECO:0000269|PubMed:7574663"
FT   CONFLICT        55
FT                   /note="M -> V (in Ref. 2; AAH62002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        79
FT                   /note="E -> N (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83..84
FT                   /note="TV -> SR (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   398 AA;  43021 MW;  25F123E67C46EB5F CRC64;
     MKPLFVLLLL LLLLDLAQAQ GVLHRVPLRR HQSLRKKLRA QGQLSDFWRS HNLDMIEFSE
     SCNVDKGINE PLINYLDMEY FGTVSIGSPS QNFTVIFDTG SSNLWVPSVY CTSPACKAHP
     VFHPSQSSTY MEVGNHFSIQ YGTGSLTGII GADQVSVEGL TVEGQQFGES VKEPGQTFVN
     AEFDGILGLG YPSLAVGGVT PVFDNMMAQN LVALPMFSVY LSSDPQGGSG SELTFGGYDP
     SHFSGSLNWI PVTKQGYWQI ALDGIQVGDT VMFCSEGCQA IVDTGTSLIT GPPKKIKQLQ
     EAIGATPMDG EYAVDCATLN MMPNVTFLIN GVSYTLSPTA YILPDLVDGM QFCGSGFQGL
     DIQPPAGPLW ILGDVFIRKF YSVFDRGNNQ VGLAPAVP
//
